Vanda Pharmaceuticals Inc. - Common Stock (VNDA)

Historical Holders from Q1 2014 to Q1 2025

Symbol
VNDA on Nasdaq
CUSIP
921659108
Type / Class
Equity / Common Stock
Shares outstanding
58M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
43.1M
Holdings value
$206M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
145
Number of buys
68
Number of sells
-68
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vanda Pharmaceuticals Inc. - Common Stock (VNDA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.1% -46.9% $21.6M -$20.2M 4.7M -48.4% BlackRock, Inc. Jan 31, 2025
BlackRock Portfolio Management LLC 7.7% $20.6M 4.48M BlackRock Portfolio Management LLC Mar 31, 2025

Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 442K $2.03M -$52.4K $4.59 10
2024 Q4 43.1M $206M -$5.28M $4.79 145
2024 Q3 43.9M $206M -$265K $4.69 150
2024 Q2 43.5M $246M -$19.6M $5.65 150
2024 Q1 47.9M $197M -$9.65M $4.11 138
2023 Q4 50.7M $214M -$19.8M $4.22 153
2023 Q3 52.5M $227M -$23M $4.32 177
2023 Q2 56.1M $369M -$15.1M $6.59 183
2023 Q1 58.2M $395M +$16.9M $6.79 174
2022 Q4 55.5M $410M +$13.8M $7.39 184
2022 Q3 41.7M $412M -$11.4M $9.88 162
2022 Q2 55.4M $602M -$3.4M $10.90 161
2022 Q1 55.9M $632M +$19M $11.31 177
2021 Q4 53.5M $839M -$31.8M $15.69 187
2021 Q3 55.2M $947M +$5.22M $17.14 174
2021 Q2 54.1M $1.16B -$3.36M $21.51 177
2021 Q1 54.1M $812M -$4.93M $15.02 180
2020 Q4 54.6M $717M +$6.5M $13.14 166
2020 Q3 54M $521M -$8.78M $9.66 154
2020 Q2 54.7M $626M +$15.8M $11.44 156
2020 Q1 53.5M $554M +$24K $10.36 149
2019 Q4 52M $854M -$1.86M $16.41 166
2019 Q3 52.1M $692M -$17.1M $13.28 156
2019 Q2 54M $761M +$14.2M $14.09 154
2019 Q1 54M $994M +$8.47M $18.40 173
2018 Q4 53M $1.38B +$26.9M $26.13 178
2018 Q3 52.2M $1.2B +$79.4M $22.95 155
2018 Q2 49M $934M +$18.6M $19.05 134
2018 Q1 48.2M $812M +$129M $16.85 131
2017 Q4 40.7M $619M +$12.4M $15.20 124
2017 Q3 39.7M $710M +$17.9M $17.90 136
2017 Q2 38.8M $633M -$6.21M $16.30 131
2017 Q1 39.5M $552M +$44M $14.00 134
2016 Q4 40.6M $648M -$10.1M $15.95 140
2016 Q3 38.9M $648M +$67.5M $16.64 136
2016 Q2 37.2M $417M -$42.2M $11.19 115
2016 Q1 41.3M $345M -$12.8M $8.36 115
2015 Q4 42.6M $396M -$31.3M $9.31 115
2015 Q3 42.7M $482M -$256K $11.28 120
2015 Q2 42M $533M -$34.8M $12.69 108
2015 Q1 46.2M $430M -$27.6M $9.30 107
2014 Q4 47.6M $681M +$76.4M $14.32 109
2014 Q3 41.3M $428M +$24.1M $10.38 101
2014 Q2 38.5M $622M +$52.9M $16.18 111
2014 Q1 35.2M $571M +$57.3M $16.25 109